Food and Drug Administration (FDA) Releases a draft five-year Plan for Rare Diseases.

Sep 28, 2011

The FDA has released a draft five-year plan for fostering rare disease drug development and help drug makers interested in developing treatments for the diseases. Training of biotech companies and outreach to the many stakeholders involved will be conducted as outlined in the report that you can read here.